Alfresa Holdings revises first-half forecast upward on strong performance

Alfresa Holdings Corporation has revised its consolidated performance forecast for the first half of fiscal year 2025, which spans from April 1, 2025, to September 30, 2025. The company now anticipates operating profit and ordinary profit to exceed initial forecasts, largely due to effective cost controls and a delay in recording certain selling, general, and administrative expenses.

The revised forecast projects net sales of 1,529,700 million yen, operating profit of 16,200 million yen, and ordinary profit of 17,400 million yen, surpassing the previous forecast by 2,200 million yen and 2,100 million yen, respectively. Profit attributable to owners of the parent is also expected to increase significantly to 11,500 million yen, an increase of 2,400 million yen, partly due to extraordinary profit from the sale of investment securities as the company reduces cross-shareholdings.

Earnings per share are now expected to be 63.24 yen, up from the previously forecast 50.06 yen. Alfresa Holdings, a leader in the Japanese healthcare industry with diversified business lines, reported consolidated revenue of 2.9 trillion yen for the fiscal year ended March 31, 2025. The full-year consolidated performance forecast for fiscal 2025 will be announced on November 6, 2025.